Egypt's c.bank chief tells AMF summit financial challenges require stronger supervisory action    Egypt's Top 50 Women launches national STEM & AI Challenge Competition    Egypt's PM reviews major healthcare expansion plan with Nile Medical City    Saudi c. bank cuts repo, reverse repo rates by 25 basis points    UN rejects Israeli claim of 'new Gaza border' as humanitarian crisis worsens    Deli Group breaks ground on new factory in 10th of Ramadan City    Egypt's Cabinet approves development of Nasser Institute into world-class medical hub    Egypt reports sharp drop in waste burning incidents during autumn 2025    Servier Egypt launches Tibsovo as first targeted therapy for IDH1-mutated cancers    UNESCO adds Egyptian Koshari to intangible cultural heritage list    Egypt's exports rise 28.2% in September 2025 as trade deficit narrows    Egyptian Cabinet prepares new data law and stricter fines to combat misinformation    Egypt, EBRD discuss boosting finance in petroleum, mining sectors    UNESCO adds Egypt's national dish Koshary to intangible cultural heritage list    Blair dropped from US Gaza governance plan after Arab objections    Egypt's Abdelatty urges rapid formation of Gaza stability force in call with Rubio    Egypt calls for inclusive Nile Basin dialogue, warns against 'hostile rhetoric'    Egypt joins Japan-backed UHC Knowledge Hub to advance national health reforms    Egypt recovers two ancient artefacts from Belgium    Egypt, Saudi nuclear authorities sign MoU to boost cooperation on nuclear safety    Giza master plan targets major hotel expansion to match Grand Egyptian Museum launch    Australia returns 17 rare ancient Egyptian artefacts    China invites Egypt to join African duty-free export scheme    Egypt calls for stronger Africa-Europe partnership at Luanda summit    Egypt begins 2nd round of parliamentary elections with 34.6m eligible voters    Egypt warns of erratic Ethiopian dam operations after sharp swings in Blue Nile flows    Egypt scraps parliamentary election results in 19 districts over violations    Filmmakers, experts to discuss teen mental health at Cairo festival panel    Egypt golf team reclaims Arab standing with silver; Omar Hisham Talaat congratulates team    Egypt launches Red Sea Open to boost tourism, international profile    Omar Hisham Talaat: Media partnership with 'On Sports' key to promoting Egyptian golf tourism    Sisi expands national support fund to include diplomats who died on duty    Egypt's PM reviews efforts to remove Nile River encroachments    Egypt resolves dispute between top African sports bodies ahead of 2027 African Games    Germany among EU's priciest labour markets – official data    Paris Olympic gold '24 medals hit record value    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Warning against use of 14 blood pressure drugs in Egypt
Ahram Online Published in Ahram Online on 26 - 07 - 2018

Egypt's consumer protection agency issued a warning in cooperation with the Ministry of Health, cautioning citizens against using 14 types of blood pressure drug, since they contain an ingredient that may cause cancer, according to a statement by the consumer protection agency.
Head of the consumer agency Rady Abdel Moaty said that the Egyptian Pharmacists Syndicate had previously issued a warning to all doctors against using any of the mentioned drugs.
The 14 drugs have been assessed as containing an excessive dosage of the active ingredient in "valsartan," which is known to be a generic agent used to treat high blood pressure and heart failure.
The substance used in valsartan is normally only used in limited proportions.
Valesartan, manufactured by a Chinese company, has been produced with higher than normal proportions of the substance according to the European Medicines Agency (EMA), causing an impurity in 14 blood pressure drugs which pose a potential cancer risk.
EMA is an agency of the European Union responsible for the scientific evaluation, supervision and safety monitoring of medicines.
According to an earlier notice issued by the Egyptian Health Ministry the 14 drugs are named as follows:
1. Valsarcard 80mg tab

5. Pressthioval tab

8. Disartan 80mg cap

12. Amilo Plus tab

2. Valsarcard Comb 80/12.5mg tab

6. Zarlodip tab

9. Disartan Co 80mg cap

13. Blokatens 5/160mg tab

3. Valsarcard Comb 160/12.5mg tab

7. Alkapress Plus 5/160mg F.C. tab

10. Disartan 160mg cap

14. Blokatens 10/160mg tab

4. Elimolivan 5/160mg tab

11. Disartan Co 160mg cap



Abdel Moaty says that the consumer protection authority has contacted all representatives of the pharmaceutical companies producing these drugs, instructing them to withdraw all of them from pharmacies immediately.
He stressed that the system would take the necessary action in cooperation with other regulatory bodies to ensure that companies would comply with the withdrawal of the drugs.
He pointed out that consumer protection campaigns will increase during the coming period to control the markets and ensure the safety of citizens.

Clic here to read the story from its source.